197 related articles for article (PubMed ID: 32251446)
21. IL-22 promoted CD3+ T cell infiltration by IL-22R induced STAT3 phosphorylation in murine acute graft versus host disease target organs after allogeneic bone marrow transplantation.
Zhao K; Ruan S; Tian Y; Zhao D; Chen C; Pan B; Yan Z; Yin L; Zhu S; Xu K
Int Immunopharmacol; 2016 Oct; 39():383-388. PubMed ID: 27551984
[TBL] [Abstract][Full Text] [Related]
22. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.
Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
J Immunol; 2005 Mar; 174(5):3051-8. PubMed ID: 15728519
[TBL] [Abstract][Full Text] [Related]
23. MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease.
Lim JY; Lee YK; Lee SE; Ju JM; Eom KS; Kim YJ; Chung NG; Jeong DC; Park G; Choi EY; Min CK
Mucosal Immunol; 2016 May; 9(3):730-43. PubMed ID: 26442657
[TBL] [Abstract][Full Text] [Related]
24. PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients.
Hossain MS; Kunter GM; El-Najjar VF; Jaye DL; Al-Kadhimi Z; Taofeek OK; Li JM; Waller EK
PLoS One; 2017; 12(9):e0184254. PubMed ID: 28953925
[TBL] [Abstract][Full Text] [Related]
25. Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality.
Saha A; Taylor PA; Lees CJ; Panoskaltsis-Mortari A; Osborn MJ; Feser CJ; Thangavelu G; Melchinger W; Refaeli Y; Hill GR; Munn DH; Murphy WJ; Serody JS; Maillard I; Kreymborg K; van den Brink M; Dong C; Huang S; Zang X; Allison JP; Zeiser R; Blazar BR
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578305
[TBL] [Abstract][Full Text] [Related]
26. Host MyD88 signaling protects against acute graft-versus-host disease after allogeneic bone marrow transplantation.
Xing S; Zhang X; Liu JH; Huang X; Zhou P
Clin Exp Immunol; 2019 Jan; 195(1):121-131. PubMed ID: 30317551
[TBL] [Abstract][Full Text] [Related]
27. SMAD3 prevents graft-versus-host disease by restraining Th1 differentiation and granulocyte-mediated tissue damage.
Giroux M; Delisle JS; Gauthier SD; Heinonen KM; Hinsinger J; Houde B; Gaboury L; Brochu S; Wu J; Hébert MJ; Perreault C
Blood; 2011 Feb; 117(5):1734-44. PubMed ID: 21119112
[TBL] [Abstract][Full Text] [Related]
28. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
[TBL] [Abstract][Full Text] [Related]
29. IL-17A/F in Leishmania major-resistant C57BL/6 mice.
Dietze-Schwonberg K; Lopez Kostka S; Lorenz B; Regen T; Waisman A; von Stebut E
Exp Dermatol; 2019 Mar; 28(3):321-323. PubMed ID: 30703249
[TBL] [Abstract][Full Text] [Related]
30. [Significance of Th1/Th17 Imbalance in Mice with Acute Graft-versus-Host Disease].
Yao Y; Pan B; Bian YP; Xia DD; Cheng H; Song GL; Zeng LY; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1488-92. PubMed ID: 26524063
[TBL] [Abstract][Full Text] [Related]
31. Differential Effects of Gut-Homing Molecules CC Chemokine Receptor 9 and Integrin-β7 during Acute Graft-versus-Host Disease of the Liver.
Schreder A; Moschovakis GL; Halle S; Schlue J; Lee CW; Schippers A; David S; Bernhardt G; Ganser A; Pabst O; Förster R; Koenecke C
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2069-2078. PubMed ID: 26348893
[TBL] [Abstract][Full Text] [Related]
32. Recipient mucosal-associated invariant T cells control GVHD within the colon.
Varelias A; Bunting MD; Ormerod KL; Koyama M; Olver SD; Straube J; Kuns RD; Robb RJ; Henden AS; Cooper L; Lachner N; Gartlan KH; Lantz O; Kjer-Nielsen L; Mak JY; Fairlie DP; Clouston AD; McCluskey J; Rossjohn J; Lane SW; Hugenholtz P; Hill GR
J Clin Invest; 2018 May; 128(5):1919-1936. PubMed ID: 29629900
[TBL] [Abstract][Full Text] [Related]
33. Rat acute GvHD is Th1 driven and characterized by predominant donor CD4
Boieri M; Shah P; Jalapothu D; Zaitseva O; Walter L; Rolstad B; Naper C; Dressel R; Inngjerdingen M
Exp Hematol; 2017 Jun; 50():33-45.e3. PubMed ID: 28238806
[TBL] [Abstract][Full Text] [Related]
34. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations.
Carlson MJ; West ML; Coghill JM; Panoskaltsis-Mortari A; Blazar BR; Serody JS
Blood; 2009 Feb; 113(6):1365-74. PubMed ID: 18957685
[TBL] [Abstract][Full Text] [Related]
35. Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4(+) T Cells after Allogeneic Stem Cell Transplantation.
Gauthier SD; Leboeuf D; Manuguerra-Gagné R; Gaboury L; Guimond M
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1721-31. PubMed ID: 26151303
[TBL] [Abstract][Full Text] [Related]
36. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.
Chen X; Vodanovic-Jankovic S; Johnson B; Keller M; Komorowski R; Drobyski WR
Blood; 2007 Nov; 110(10):3804-13. PubMed ID: 17693581
[TBL] [Abstract][Full Text] [Related]
37. Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease.
Zhao K; Ruan S; Yin L; Zhao D; Chen C; Pan B; Zeng L; Li Z; Xu K
Mol Med Rep; 2016 Feb; 13(2):1395-403. PubMed ID: 26647759
[TBL] [Abstract][Full Text] [Related]
38. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-22 aggravates murine acute graft-versus-host disease by expanding effector T cell and reducing regulatory T cell.
Zhao K; Zhao D; Huang D; Yin L; Chen C; Pan B; Wu Q; Li Z; Yao Y; Shen E; Zeng L; Xu K
J Interferon Cytokine Res; 2014 Sep; 34(9):707-15. PubMed ID: 24720737
[TBL] [Abstract][Full Text] [Related]
40. TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis.
Wedebye Schmidt EG; Larsen HL; Kristensen NN; Poulsen SS; Lynge Pedersen AM; Claesson MH; Pedersen AE
Inflamm Bowel Dis; 2013 Jul; 19(8):1567-76. PubMed ID: 23689808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
